Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction

Abstract

The results of this study suggest a role for autoantibodies in the identification of patients with psoriasis at higher risk of developing infliximab-Abs and of LOR under treatment with infliximab.